Evidence map›Paper›PMID 31035990›Full record

ArticleBMC public health2019

Epidemiology of hepatitis B virus infection in people living in poverty in the central-west region of Brazil.

Lara Cristina da Cunha Guimarães, Sandra Brunini, Rafael Alves Guimarães, Hélio Galdino-Júnior, Ruth Minamisava, Vanessa Elias da Cunha, Jordana Rúbia Souza Santos, Elisângela de Paula Silveira-Lacerda, Christiane Moreira Souza, Vera Lúcia Brandão de Oliveira and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Hepatitis B and circadian rhythm of the liver.World journal of gastroenterology · 2022
    Review
  9. Observational
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Lara Cristina da Cunha GuimarãesFaculty of Nursing, Federal University of Goiás, Goiânia, Goiás, Brazil.
Sandra BruniniFaculty of Nursing, Federal University of Goiás, Goiânia, Goiás, Brazil.
Rafael Alves GuimarãesInstituto de Patologia Tropical e Saúde Pública, Federal University of Goiás, Goiânia, Goiás, Brazil.
Hélio Galdino-JúniorFaculty of Nursing, Federal University of Goiás, Goiânia, Goiás, Brazil.
Ruth MinamisavaFaculty of Nursing, Federal University of Goiás, Goiânia, Goiás, Brazil.
Vanessa Elias da CunhaFaculty of Nursing, Federal University of Goiás, Goiânia, Goiás, Brazil.
Jordana Rúbia Souza SantosFaculty of Nursing, Federal University of Goiás, Goiânia, Goiás, Brazil.
Elisângela de Paula Silveira-LacerdaInstituto de Ciências Biológicas, Federal University of Goiás, Goiânia, Goiás, Brazil.
Christiane Moreira SouzaFaculty of Nursing, Federal University of Goiás, Goiânia, Goiás, Brazil.
Vera Lúcia Brandão de OliveiraLaboratório de Análises Clínicas e Estudo em Saúde (LACES), Federal University of Goiás, Goiânia, Goiás, Brazil.
Gabriela Cavalcante AlbernazFaculty of Nursing, Federal University of Goiás, Goiânia, Goiás, Brazil.
Thiago Guida de MenezesSecretaria de Estado da Saúde de Goiás/Coordenação Estadual de Controle das Hepatites Virais - CECHV, Goiânia, Goiás, Brazil.
Giovanni RezzaDepartment of Infectious Diseases, Istituto Superiore di Sanitá, Rome, Italy. giovanni.rezza@iss.it.
Universidade Federal de Goiás · BRIstituto Superiore di Sanità · ITSecretaria da Saúde · BR

Funding

Programa de Extensão Universitária (ProExt) PROEXT 2016
6 · The paper itself

Abstract

backgroundPeople living in poverty (PLP) are highly vulnerable to hepatitis B virus (HBV) infection. This study aimed to investigate the epidemiology of HBV infection in PLP in the metropolitan region of Goiânia, Goiás State, in the Central-West Region of Brazil.

methodsA cross-sectional study was conducted from August to December 2016 in adults aged ≥12 years living in poverty. The following serological markers for HBV were investigated: hepatitis B surface antigen (HBsAg), antibody to HBV core antigen (total anti-HBc), IgM anti-HBc, and hepatitis B surface antibody (anti-HBs), which were detected by enzyme-linked immunosorbent assay (ELISA). Poisson regression analysis with robust variance was performed to verify the factors associated with HBV exposure.

resultsThe study included 378 participants. The overall prevalence rate of HBV (any viral marker) was 9.8% (95% confidence interval [CI], 7.2-13.2). The prevalence rate of HBsAg in combination with total anti-HBc was 0.8% (95% CI, 0.3-2.4), total anti-HBc in combination with anti-HBs was 7.7% (95% CI, 5.4-10.9), and total anti-HBc alone was 1.3% (95% CI, 0.5-3.0) in the population. Furthermore, isolated positivity for anti-HBs was identified in only 25.4% (95% CI, 21.3-30.0) of the participants. Multiple regression analysis revealed that age (adjusted prevalence ratio [APR], 1.04; 95% CI, 1.01-1.07), female sex (APR, 2.18; 95% CI, 1.01-4.73), sexual intercourse under the influence of alcohol (APR, 2.49; 95% CI, 1.36-7.06), and exposure to Treponema pallidum (APR, 3.10; 95% CI, 1.36-7.06) were associated with HBV exposure.

conclusionThere was a high prevalence of HBV exposure in PLP in the Central-West Region of Brazil, indicating significant viral spread of the infection. Additionally, there was low serological evidence of immunisation against hepatitis B, indicating that a large proportion of the participants in this study are susceptible to the infection. The results support the need for public health policies that facilitate access to the existing healthcare services in hard-to-reach groups with special regard to immunisation programmes against hepatitis B.

Indexed as

AdultAge FactorsBiomarkersBrazilCross-Sectional StudiesEnzyme-Linked Immunosorbent AssayFemaleHepatitis BHepatitis B AntibodiesHepatitis B Surface AntigensHepatitis B virusHumansMalePovertyPrevalenceRegression AnalysisBiomarkersHepatitis B AntibodiesHepatitis B Surface AntigensEpidemiology, immunisationHepatitis B infectionPoverty

Identifiers

PMID31035990
PMCPMC6489193
OpenAlexW2947796050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.